Relationship between lipophilicity and brain uptake of azomethine prodrugs of a histamine H 3-receptor agonist

Scientia Pharmaceutica

Volumn 64, Issue 3-4, 1996, Pages 503-509

  Krause, M ^a   Rouleau, A ^b   Stark, H ^a   Garbarg, M ^b   Schwartz, J C ^b   Schunack, W ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CENTRE PAUL BROCA   (France)

Author keywords

agonist; azomethine; H 3 receptor; histamine; prodrug

Indexed keywords

ANTIHISTAMINIC AGENT; AZO COMPOUND; HISTAMINE H3 RECEPTOR AGONIST; PRODRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BRAIN; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG UPTAKE; IN VIVO STUDY; LIPOPHILICITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0029774725     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Arrang J.-M. Garbarg M., Schwartz J.-C. (1983), Nature (London) 302: 832.
2. Arrang J.-M, Garbarg M., Schwartz J.-C. (1985), Neuroscience 15: 553.
3. Arrang J.-M, Garbarg M., Schwartz J -C. (1987), Neuroscience 23: 149.
4. Schlicker E., Malinowska B., Kathmann M., Göthert M. (1994), Fundam. Clin. Pharmacol. 8: 128.
5. Ligneau X., Garbarg M., Vizuette M. L., Diaz J., Purand K., Stark H., Schunack W., Schwartz J.-C. (1994), J. Pharmacol. Exper. Ther. 271: 452.
6. Krause M., Rouleau A., Stark H., Luger P., Lipp R., Garbarg M., Schwartz J.-C., Schunack W. (1995), J. Med. Chem. 38: 4070.
7. Krause M., Rouleau A., Stark H., Luger P., Garbarg M., Schwartz J.-C., Schunack W. (1996), Arch. Pharm. Pharm. Med. Chem. in press.
8. Arrang J.-M., Garbarg M., Lancelot J.-C., Lecomte J.-M., Pollard H., Robba M., Schunack W., Schwartz J.-C. (1987), Nature (London) 327: 117.
9. Yamazaki S., Sakurai E., Hikichi N., Sakai N., Maeyama K., Watanabe T. (1994), J. Pharm. Pharmacol. 46: 371.
10. Rouleau A., Garbarg M., Ligneau X., Mantion C., Lavie P., Advenier C., Lecomte J.-M., Krause M., Stark H., Schunack W., Schwartz J.-C. (1996), J. Pharmacol. Exp. Ther. submitted.
11. Garbarg M., Arrang J.-M., Schunack W., Lipp R., Stark H., Lecomte J.-M., Schwartz J.-C. (30.08.1994) US 5,342,960.
12. Matsubara T., Moskowitz M. A., Huang Z. (1992), Eur. J. Pharmacol. 224: 145.
13. Lin J. S., Sakai K., Vanni-Mercier G., Arrang J.-M., Garbarg M., Schwartz J.-C., Jouvet M. (1990), Brain Res. 523: 325.
14. Boyce C. B. C., Milborrow B. V. (1965), Nature (London) 208: 537.
15. Rekker R. F., Mannhold R. (1992), Calculation of Drug Lipophilicity, VCH Verlagsgesellschaft mbH, Weinheim.
16. Begley D J. (1996), J. Pharm. Pharmacol. 48: 136.
17. Black J. W., Ganellin C. R. (1974), Experientia 30: 111.